Terms: = Ovarian cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Diagnosis
19 results:
1. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract] [Full Text] [Related]
2. CT imaging phenotypes linked to CA125 and HE4 biomarkers are highly predictive in discriminating between hereditary and sporadic ovarian cancer patients.
Manganaro L; Celli V; Viggiani V; Berardelli E; Granato T; Tartaglione S; Farina A; Catalano C; Angeloni A; Anastasi E
Tumour Biol; 2022; 44(1):171-185. PubMed ID: 36093649
[TBL] [Abstract] [Full Text] [Related]
3. Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential diagnosis Staging, and Prognostic Factors.
Devins KM; Young RH; Ghioni M; Burandt E; Bennett JA; Oliva E
Am J Surg Pathol; 2022 Nov; 46(11):1477-1489. PubMed ID: 35941719
[TBL] [Abstract] [Full Text] [Related]
4. Establishment and Verification of Logistic Regression Model for Qualitative diagnosis of ovarian cancer Based on MRI and Ultrasound Signs.
Guo X; Zhao G
Comput Math Methods Med; 2022; 2022():7531371. PubMed ID: 35211186
[TBL] [Abstract] [Full Text] [Related]
5. A turn on fluorescent assay for real time determination of β-galactosidase and its application in living cell imaging.
Liu D; Zhang Z; Chen A; Zhang P
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jan; 265():120345. PubMed ID: 34492512
[TBL] [Abstract] [Full Text] [Related]
6. Markedly increased risk of malignancies in women with endometriosis.
Eoh KJ; Han M; Kim EH; Jung I; Kim YT
Gynecol Oncol; 2021 Apr; 161(1):291-296. PubMed ID: 33514482
[TBL] [Abstract] [Full Text] [Related]
7. Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort.
Peretti U; Cavaliere A; Niger M; Tortora G; Di Marco MC; Rodriquenz MG; Centonze F; Rapposelli IG; Giordano G; De Vita F; Stuppia L; Avallone A; Ratti M; Paratore C; Forti LG; Orsi G; Valente MM; Gaule M; Macchini M; Carrera P; Calzavara S; Simbolo M; Melisi D; De Braud F; Salvatore L; De Lorenzo S; Chiarazzo C; Falconi M; Cascinu S; Milella M; Reni M
ESMO Open; 2021 Feb; 6(1):100032. PubMed ID: 33399070
[TBL] [Abstract] [Full Text] [Related]
8. Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.
Chen C; Xu Y; Huang X; Mao F; Shen S; Xu Y; Sun Q
Medicine (Baltimore); 2020 Aug; 99(32):e21560. PubMed ID: 32769897
[TBL] [Abstract] [Full Text] [Related]
9. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial ovarian cancer.
Melamed A; Rizzo AE; Nitecki R; Gockley AA; Bregar AJ; Schorge JO; Del Carmen MG; Rauh-Hain JA
Obstet Gynecol; 2017 Jul; 130(1):71-79. PubMed ID: 28594773
[TBL] [Abstract] [Full Text] [Related]
10. Commonest cancers in Pakistan - Findings and Histopathological Perspective from a Premier Surgical Pathology Center in Pakistan.
Ahmad Z; Idrees R; Fatima S; Uddin N; Ahmed A; Minhas K; Memon A; Fatima SS; Arif M; Hasan S; Ahmed R; Pervez S; Kayani N
Asian Pac J Cancer Prev; 2016; 17(3):1061-75. PubMed ID: 27039726
[TBL] [Abstract] [Full Text] [Related]
11. Obesity, weight gain, and ovarian cancer risk in African American women.
Bandera EV; Qin B; Moorman PG; Alberg AJ; Barnholtz-Sloan JS; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry P; Schildkraut JM
Int J Cancer; 2016 Aug; 139(3):593-600. PubMed ID: 27038123
[TBL] [Abstract] [Full Text] [Related]
12. A Systematic Review of Symptoms for the diagnosis of ovarian cancer.
Ebell MH; Culp MB; Radke TJ
Am J Prev Med; 2016 Mar; 50(3):384-394. PubMed ID: 26541098
[TBL] [Abstract] [Full Text] [Related]
13. The clinical and diagnostic role of microRNAs in ovarian carcinoma.
Davidson B; Tropé CG; Reich R
Gynecol Oncol; 2014 Jun; 133(3):640-6. PubMed ID: 24713546
[TBL] [Abstract] [Full Text] [Related]
14. Pelvic tuberculosis, echinococcosis, and actinomycosis: great imitators of ovarian cancer.
Ertas IE; Gungorduk K; Ozdemir A; Emirdar V; Gokcu M; Dogan A; Solmaz U; Yildirim Y
Aust N Z J Obstet Gynaecol; 2014 Apr; 54(2):166-71. PubMed ID: 24506530
[TBL] [Abstract] [Full Text] [Related]
15. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.
Kotsopoulos J; Lubinski J; Moller P; Lynch HT; Singer CF; Eng C; Neuhausen SL; Karlan B; Kim-Sing C; Huzarski T; Gronwald J; McCuaig J; Senter L; Tung N; Ghadirian P; Eisen A; Gilchrist D; Blum JL; Zakalik D; Pal T; Sun P; Narod SA;
Breast Cancer Res Treat; 2014 Feb; 143(3):579-86. PubMed ID: 24458845
[TBL] [Abstract] [Full Text] [Related]
16. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract] [Full Text] [Related]
17. Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis.
Vay A; Kumar S; Seward S; Semaan A; Schiffer CA; Munkarah AR; Morris RT
Gynecol Oncol; 2011 Dec; 123(3):456-60. PubMed ID: 21855120
[TBL] [Abstract] [Full Text] [Related]
18. Endometriosis and the risk of cancer with special emphasis on ovarian cancer.
Melin A; Sparén P; Persson I; Bergqvist A
Hum Reprod; 2006 May; 21(5):1237-42. PubMed ID: 16431901
[TBL] [Abstract] [Full Text] [Related]
19. [Clinical analysis of benign pelvic mass with high serum levels of CA(125)].
Zhang X; Wu LY; Li XJ; Li HJ; Zhang R; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):178-82. PubMed ID: 15840313
[TBL] [Abstract] [Full Text] [Related]
